Two Indian drugmakers to end trials of generic Merck pill for...

a partagé un lien

2021-10-26 23:04:57

."Donc quand 2 grands fabricants de médicaments génériques en #Inde stoppent leur essai du #Molnupiravir de #Merck, parce qu'il ne marche pas sur les #Covid19 modérés...
#Véran en commande 50.000 doses."
Francis Lalanne

https://reuters.com/business/healthcare-pharmaceuticals/aurobindo-pharma-stop-molnupiravir-trial-moderate-covid-19-patients-2021-10-08/ https://businesswire.com/news/home/20210415005258/en/ https://lavoixdunord.fr/1090028/article/2021-10-26/c-est-quoi-le-molnupiravir-medicament-anti-covid-dont-la-france-commande-50-000

."Donc quand 2 grands fabricants de médicaments génériques en #Inde stoppent leur essai du #Molnupiravir de #Merck, parce qu'il ne marche pas sur les #Covid19 modérés... #Véran en commande 50.000 doses." Francis Lalanne https://reuters.com/business/healthcare-pharmaceuticals/aurobindo-pharma-stop-molnupiravir-trial-moderate-covid-19-patients-2021-10-08/ https://businesswire.com/news/home/20210415005258/en/ https://lavoixdunord.fr/1090028/article/2021-10-26/c-est-quoi-le-molnupiravir-medicament-anti-covid-dont-la-france-commande-50-000

Two Indian drugmakers to end trials of generic Merck pill for moderate COVID-19

Two Indian drugmakers have requested permission to end late-stage trials of their generic versions of Merck & Co's promising experimental oral antiviral drug molnupiravir to treat moderate COVID-19, a week after Merck said its own trial had succeeded for mild-to-moderate patients.

0 Commentaires 0 Partages 482 Vues 0 Notes